Gelonghui, January 30丨Shilong Industrial (002748.SZ) announced its 2023 annual performance forecast. Net profit attributable to shareholders of listed companies during the reporting period was 16 million yuan to 24 million yuan, down 91.12% -86.68% from the same period last year; net profit loss after deducting non-recurring profit and loss was 8 million yuan to 16 million yuan, down 104.48% to 108.96% from the same period last year; basic profit per share was 0.067 yuan/share — 0.100 yuan/share.
The main reasons for the year-on-year decline in the company's 2023 business performance are as follows:
1. In 2023, the sales prices of the leading products of the company and its subsidiary, Jiangxi Shilong Biotechnology Co., Ltd. (hereinafter referred to as “Biotechnology”), such as AC foaming agent, caustic soda, hydrazine hydrate, sulfoxide, p-chlorobenzaldehyde and o-chlorobenzonitrile, all fell sharply compared to the same period last year, and the company's sales revenue dropped sharply; at the same time, the company's bulk raw material procurement costs declined less than the sales price of major products. The product gross margin dropped significantly year-on-year, and the company's operating performance declined year-on-year;
2. During the reporting period, the company's subsidiaries transferred about 8 million yuan of deferred income tax expenses that could not be deferred;
3. During the reporting period, the impact of non-recurring profit and loss on net profit attributable to shareholders of listed companies was about 30 million yuan to 35 million yuan, mainly including: first, Shanghai Yongken Chemical Co., Ltd. and Shen Yong offset part of their debts with biotechnology shares held under their names, and the company transferred back the corresponding accounts receivable bad debt to prepare about 30 million yuan; second, the company was recognized as an advanced manufacturing enterprise to enjoy 5% off the benefit-enterprise policy. During the reporting period, VAT can be deducted from the input tax amount plus about 5% off the corporate benefit policy. More than ten thousand yuan. The increase in non-recurring profit and loss mentioned above had a favorable impact on the company's current profit.